Does excess glucose and fatty acid delivery to the liver raise triglycerides and cholesterol?

Excess hepatic nutrient delivery triggers a cascade of metabolic remodeling that directly drives systemic dyslipidemia.

Mechanistic pathways of hepatic lipogenesis

• Transcriptional activation: Excess delivery of glucose and carbohydrate substrates to hepatocytes activates key lipogenic transcription factors, specifically carbohydrate-responsive element-binding protein (ChREBP) and sterol regulatory element-binding protein 1c (SREBP-1c). This upregulates crucial enzymes like acetyl-CoA carboxylase (ACC) and fatty acid synthase (FASN) to accelerate de novo lipogenesis (DNL), which can contribute up to 25–30% of the hepatic triglyceride pool.
• VLDL assembly and secretion: The resulting accumulation of intracellular triglycerides (from both DNL and circulating free fatty acid influx) stabilizes apolipoprotein B-100 (apoB-100) by preventing its endoplasmic reticulum-associated degradation (ERAD). Guided by microsomal triglyceride transfer protein (MTP), this lipid pool drives the assembly and hypersecretion of large, triglyceride-rich VLDL particles.

Systemic lipid consequences

• Triglyceride and cholesterol remodeling: Elevated hepatic secretion of VLDL directly increases circulating systemic triglycerides. Concurrently, cholesteryl ester transfer protein (CETP) facilitates lipid exchange between VLDL and other lipoproteins, leading to downstream plasma remodeling. This process converts VLDL remnants into cholesterol-dense intermediate-density lipoproteins (IDL) and low-density lipoproteins (LDL), ultimately driving up systemic triglycerides and cholesterol.

Bottom line

• Excess hepatic glucose and fatty acid delivery directly stimulates de novo lipogenesis and VLDL hypersecretion, accelerating the output of triglyceride-rich lipoproteins and raising systemic triglycerides and atherogenic cholesterol.